Lipodermatosclerosis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Lipodermatosclerosis | |||
| image = [[File:Chronicvenousinsufficiency.jpg|250px]] | |||
| caption = Chronic venous insufficiency, a condition associated with lipodermatosclerosis | |||
| synonyms = Sclerosing panniculitis, Hypodermitis sclerodermiformis | |||
| specialty = [[Dermatology]], [[Vascular medicine]] | |||
| symptoms = [[Pain]], [[skin]] [[induration]], [[hyperpigmentation]], [[swelling]] | |||
| complications = [[Venous ulcer]], [[infection]] | |||
| onset = Typically [[middle-aged]] to [[elderly]] | |||
| duration = [[Chronic (medicine)|Chronic]] | |||
| causes = [[Chronic venous insufficiency]] | |||
| risks = [[Obesity]], [[sedentary lifestyle]], [[deep vein thrombosis]] | |||
| diagnosis = [[Clinical diagnosis]], [[Doppler ultrasound]] | |||
| differential = [[Cellulitis]], [[Lymphedema]], [[Erythema nodosum]] | |||
| treatment = [[Compression therapy]], [[topical corticosteroids]], [[surgery]] | |||
| medication = [[Pentoxifylline]], [[Flavonoids]] | |||
| frequency = Common in individuals with [[chronic venous disease]] | |||
}} | |||
'''Lipodermatosclerosis''' is a skin and connective tissue disease characterized by inflammation of the subcutaneous fat layer, often associated with [[chronic venous insufficiency]]. It is also known as sclerosing panniculitis or hypodermitis sclerodermiformis. | '''Lipodermatosclerosis''' is a skin and connective tissue disease characterized by inflammation of the subcutaneous fat layer, often associated with [[chronic venous insufficiency]]. It is also known as sclerosing panniculitis or hypodermitis sclerodermiformis. | ||
== Pathophysiology == | == Pathophysiology == | ||
Lipodermatosclerosis is thought to result from long-standing [[venous hypertension]] and [[venous stasis]], which lead to increased pressure in the capillaries and subsequent leakage of fibrinogen and other proteins into the surrounding tissue. This process causes inflammation and fibrosis of the skin and subcutaneous tissues. | Lipodermatosclerosis is thought to result from long-standing [[venous hypertension]] and [[venous stasis]], which lead to increased pressure in the capillaries and subsequent leakage of fibrinogen and other proteins into the surrounding tissue. This process causes inflammation and fibrosis of the skin and subcutaneous tissues. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Patients with lipodermatosclerosis typically present with induration, hyperpigmentation, and pain in the lower legs. The skin may appear red, brown, or purple, and the affected area is often tender to touch. In chronic cases, the skin may become hardened and resemble an inverted champagne bottle. | Patients with lipodermatosclerosis typically present with induration, hyperpigmentation, and pain in the lower legs. The skin may appear red, brown, or purple, and the affected area is often tender to touch. In chronic cases, the skin may become hardened and resemble an inverted champagne bottle. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of lipodermatosclerosis is primarily clinical, based on the characteristic appearance of the skin and the presence of underlying venous disease. [[Doppler ultrasound]] may be used to assess venous insufficiency and rule out other conditions such as [[deep vein thrombosis]]. | Diagnosis of lipodermatosclerosis is primarily clinical, based on the characteristic appearance of the skin and the presence of underlying venous disease. [[Doppler ultrasound]] may be used to assess venous insufficiency and rule out other conditions such as [[deep vein thrombosis]]. | ||
== Treatment == | == Treatment == | ||
Treatment of lipodermatosclerosis focuses on managing the underlying venous insufficiency and alleviating symptoms. This may include: | Treatment of lipodermatosclerosis focuses on managing the underlying venous insufficiency and alleviating symptoms. This may include: | ||
| Line 16: | Line 31: | ||
* [[Pentoxifylline]] to improve blood flow. | * [[Pentoxifylline]] to improve blood flow. | ||
* [[Surgery]] or [[endovenous ablation]] to address venous reflux. | * [[Surgery]] or [[endovenous ablation]] to address venous reflux. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for lipodermatosclerosis varies depending on the severity of the underlying venous disease and the effectiveness of treatment. Early intervention can prevent progression and improve symptoms, but chronic cases may lead to persistent skin changes and ulceration. | The prognosis for lipodermatosclerosis varies depending on the severity of the underlying venous disease and the effectiveness of treatment. Early intervention can prevent progression and improve symptoms, but chronic cases may lead to persistent skin changes and ulceration. | ||
== See Also == | |||
== | |||
* [[Chronic venous insufficiency]] | * [[Chronic venous insufficiency]] | ||
* [[Venous ulcer]] | * [[Venous ulcer]] | ||
* [[Varicose veins]] | * [[Varicose veins]] | ||
* [[Panniculitis]] | * [[Panniculitis]] | ||
{{Dermatology}} | {{Dermatology}} | ||
{{Vascular diseases}} | {{Vascular diseases}} | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Vascular diseases]] | [[Category:Vascular diseases]] | ||
Latest revision as of 03:17, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Lipodermatosclerosis | |
|---|---|
| |
| Synonyms | Sclerosing panniculitis, Hypodermitis sclerodermiformis |
| Pronounce | N/A |
| Specialty | Dermatology, Vascular medicine |
| Symptoms | Pain, skin induration, hyperpigmentation, swelling |
| Complications | Venous ulcer, infection |
| Onset | Typically middle-aged to elderly |
| Duration | Chronic |
| Types | N/A |
| Causes | Chronic venous insufficiency |
| Risks | Obesity, sedentary lifestyle, deep vein thrombosis |
| Diagnosis | Clinical diagnosis, Doppler ultrasound |
| Differential diagnosis | Cellulitis, Lymphedema, Erythema nodosum |
| Prevention | N/A |
| Treatment | Compression therapy, topical corticosteroids, surgery |
| Medication | Pentoxifylline, Flavonoids |
| Prognosis | N/A |
| Frequency | Common in individuals with chronic venous disease |
| Deaths | N/A |
Lipodermatosclerosis is a skin and connective tissue disease characterized by inflammation of the subcutaneous fat layer, often associated with chronic venous insufficiency. It is also known as sclerosing panniculitis or hypodermitis sclerodermiformis.
Pathophysiology[edit]
Lipodermatosclerosis is thought to result from long-standing venous hypertension and venous stasis, which lead to increased pressure in the capillaries and subsequent leakage of fibrinogen and other proteins into the surrounding tissue. This process causes inflammation and fibrosis of the skin and subcutaneous tissues.
Clinical Presentation[edit]
Patients with lipodermatosclerosis typically present with induration, hyperpigmentation, and pain in the lower legs. The skin may appear red, brown, or purple, and the affected area is often tender to touch. In chronic cases, the skin may become hardened and resemble an inverted champagne bottle.
Diagnosis[edit]
Diagnosis of lipodermatosclerosis is primarily clinical, based on the characteristic appearance of the skin and the presence of underlying venous disease. Doppler ultrasound may be used to assess venous insufficiency and rule out other conditions such as deep vein thrombosis.
Treatment[edit]
Treatment of lipodermatosclerosis focuses on managing the underlying venous insufficiency and alleviating symptoms. This may include:
- Compression therapy to reduce venous pressure and improve circulation.
- Topical corticosteroids to reduce inflammation.
- Pentoxifylline to improve blood flow.
- Surgery or endovenous ablation to address venous reflux.
Prognosis[edit]
The prognosis for lipodermatosclerosis varies depending on the severity of the underlying venous disease and the effectiveness of treatment. Early intervention can prevent progression and improve symptoms, but chronic cases may lead to persistent skin changes and ulceration.
See Also[edit]
| Cardiovascular disease (vessels) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
